NCT02365675 is a NA clinical trial of Cotton gauze with petrolatum in Pemphigus, sponsored by Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C..

What drugs are being tested in NCT02365675?

Interventions in NCT02365675: Cotton gauze with petrolatum, Cellulose acetate with petrolatum, Nanocrystalline silver (Acticoat), Carboxymethylcellulose with ionic silver (Aquacel Ag).

What condition does NCT02365675 study?

NCT02365675 studies Pemphigus, Pemphigoid.

Is NCT02365675 still recruiting?

NCT02365675 is currently status unknown. Last updated 18 February 2015.

Last reviewed 2015-02-18 · How we verify

NCT02365675

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid

Status unknown NA Last updated 18 February 2015

What this trial tests

NA trial testing Cotton gauze with petrolatum in Pemphigus in 12 participants. Status unknown.

Timeline

1 January 2015

Primary endpoint
1 January 2016

1 June 2016

Quick facts

Lead sponsor	Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	12
Start date	1 January 2015
Primary completion	1 January 2016
Estimated completion	1 June 2016
Sites	2 locations across Mexico

Drugs / interventions tested

Cotton gauze with petrolatum
Cellulose acetate with petrolatum
Nanocrystalline silver (Acticoat)
Carboxymethylcellulose with ionic silver (Aquacel Ag)

Conditions studied

Pemphigus — all drugs for Pemphigus →
Pemphigoid — all drugs for Pemphigoid →

Sponsor

Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C. — full company profile →

Who can join

18 and older, any sex, with Pemphigus or Pemphigoid. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Wound Healing Percentage of a 64 cm2 area of epithelialized skin
Time frame: 42 days
Percentage of a 64 cm2 area of epithelialized skin

Sponsor's own description

The purpose of this study is to compare the efficacy of four dressings (covers) namely: gauze with petrolatum , cellulose acetate with petrolatum , pure carboxymethylcellulose with silver and nanocrystalline silver to improve the new growth of skin, reduce pain and itch in persons suffering from pemphigus and pemphigoid.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems.
Chandrakala V, Aruna V, Angajala G. · · 2022 · cited 286× · PMID 35005431 · DOI 10.1007/s42247-021-00335-x
Borrowing the Features of Biopolymers for Emerging Wound Healing Dressings: A Review.
Gardikiotis I, Cojocaru FD, Mihai CT, Balan V, et al · · 2022 · cited 33× · PMID 35955912 · DOI 10.3390/ijms23158778
Interventions for bullous pemphigoid.
Singh S, Kirtschig G, Anchan VN, Chi CC, et al · · 2023 · cited 9× · PMID 37572360 · DOI 10.1002/14651858.cd002292.pub4

Verify or expand the search:

Other recruiting trials for Pemphigus

Currently open trials in the same condition.

NCT05898308 — Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus · Phase 4 · recruiting
NCT06454357 — A Clinical Study of B007 in the Treatment of Pemphigus. · Phase 2, PHASE3 · recruiting
NCT06696716 — ONO-4059 Study in Patients With Steroid-resistant Pemphigus · Phase 3 · recruiting
NCT04400994 — IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus · Phase 2 · active not recruiting
NCT05954416 — FARD (RaDiCo Cohort) (RaDiCo-FARD) · recruiting

Other Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C. trials

Trials by the same sponsor.

NCT04258930 — Occlusion vs Standard Treatment for the Treatment of Herpes Zoster · NA · unknown
NCT06909812 — Silicone vs Pirfenidone in the Treatment of Hypertrophic Scars and Keloids · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02365675 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.
Last refreshed: 18 February 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02365675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing